Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans

Journal of Leukocyte Biology
Dorothy Yeboah-ManuClaudia A Daubenberger

Abstract

Buruli ulcer (BU), caused by Mycobacterium ulcerans, is the third most common mycobacterial infection in immunocompetent humans besides tuberculosis and leprosy. We have compared by ex vivo enzyme-linked immunospot analysis interferon-gamma (IFN-gamma) responses in peripheral blood mononuclear cells (PBMC) from BU patients, household contacts, and individuals living in an adjacent M. ulcerans nonendemic region. PBMC were stimulated with purified protein derivative (PPD) and nonmycobacterial antigens such as reconstituted influenza virus particles and isopentenyl-pyrophosphate. With all three antigens, the number of IFN-gamma spot-forming units was reduced significantly in BU patients compared with the controls from a nonendemic area. This demonstrates for the first time that M. ulcerans infection-associated systemic reduction in IFN-gamma responses is not confined to stimulation with live or dead mycobacteria and their products but extends to other antigens. Interleukin (IL)-12 secretion by PPD-stimulated PBMC was not reduced in BU patients, indicating that reduction in IFN-gamma responses was not caused by diminished IL-12 production. Several months after surgical excision of BU lesions, IFN-gamma responses of BU patients agai...Continue Reading

Citations

Dec 17, 2008·Nature Reviews. Microbiology·Caroline DemangelStewart T Cole
May 23, 2007·The Journal of Experimental Medicine·Emmanuelle CoutanceauCaroline Demangel
Nov 13, 2010·PLoS Neglected Tropical Diseases·Sacha J PidotTimothy P Stinear
Apr 12, 2014·PLoS Neglected Tropical Diseases·Richard O PhillipsCaroline Demangel
Jan 22, 2014·Cellular and Molecular Life Sciences : CMLS·Laure Guenin-MacéCaroline Demangel
Feb 10, 2009·Medical Microbiology and Immunology·Kris HuygenFrançoise Portaels
Nov 2, 2013·Natural Product Reports·Anne-Caroline ChanyNicolas Blanchard
Apr 1, 2008·Expert Opinion on Drug Discovery·Claudia A DaubenbergerNicole Westerfeld
Oct 28, 2006·The Journal of Investigative Dermatology·Elisabetta PeduzziClaudia Andrea Daubenberger
Sep 29, 2007·Clinical and Experimental Immunology·H S SchipperT S van der Werf
Oct 23, 2010·International Journal of Dermatology·Elisa ZavattaroGiorgio Leigheb
Apr 21, 2010·Australian Veterinary Journal·A van ZylJ A Fyfe
May 29, 2015·Science Translational Medicine·Laure Guenin-MacéCaroline Demangel
Nov 21, 2009·Clinics in Chest Medicine·T Mark DohertyAlimuddin Zumla
Jun 10, 2015·The American Journal of Tropical Medicine and Hygiene·Joseph TuffourDorothy Yeboah-Manu
Jul 29, 2018·Biology of the Cell·Caroline Demangel, Stephen High
Sep 1, 2018·Journal of Leukocyte Biology·Sammy Yaw AboagyeDorothy Yeboah-Manu
Dec 15, 2010·PLoS Neglected Tropical Diseases·Claire L GordonPaul D R Johnson
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rachel E SimmondsBrian M Foxwell
Jan 1, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sheerazed BoulkrounCaroline Demangel
Dec 17, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Egídio TorradoJorge Pedrosa
Feb 20, 2021·Immunological Reviews·Caroline Demangel
Mar 9, 2021·Immunological Reviews·João FevereiroJorge Pedrosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.